Evolution in health and medicine Sackler colloquium: a public choice framework for controlling transmissible and evolving diseases.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 20018681.
- Also identified by DOI 10.1073/pnas.0906078107 and PMC identifier 2868281.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Control measures used to limit the spread of infectious disease often generate externalities. Vaccination for transmissible diseases can reduce the incidence of disease even among the unvaccinated, whereas antimicrobial chemotherapy can lead to the evolution of antimicrobial resistance and thereby limit its own effectiveness over time. We integrate the economic theory of public choice with mathematical models of infectious disease to provide a quantitative framework for making allocation decisions in the presence of these externalities. To illustrate, we present a series of examples: vaccination for tetanus, vaccination for measles, antibiotic treatment of otitis media, and antiviral treatment of pandemic influenza.
Medical subject headings
- Communicable Disease Control